🎁 Black Friday: up to 50% off of annual plans
G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
22.50
-2.50 (-10.00%)
Nov 20, 2026, 1:30 PM CST

G&E Herbal Biotechnology Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
55.36139.2102.0672.47.38-19.88
Depreciation & Amortization
10.710.6110.389.339.49.33
Other Amortization
-----0
Loss (Gain) From Sale of Assets
0.030.030.010.0100.02
Other Operating Activities
-32.8812.3222.517.980.711.67
Change in Accounts Receivable
6.230.74-3.04-14.194.381.08
Change in Inventory
0.22-3.591.21.74-5.69-2.85
Change in Accounts Payable
0.13-0.551.42-22.47-0.35
Change in Unearned Revenue
-26.33-85.1-10.0123.3971.390.28
Change in Other Net Operating Assets
-17.87-3.4910.164.829.921.52
Operating Cash Flow
-4.4170.18134.68113.4899.96-9.19
Operating Cash Flow Growth
--47.89%18.68%13.52%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3.13-3.2-5.92-5.52-2.95-1.77
Sale (Purchase) of Intangibles
-0.37--0.08--0.01-0.22
Investment in Securities
70-95.61-83.05-82.045.49
Other Investing Activities
---0.19-0.870.07-
Investing Cash Flow
66.5-98.82-89.24-88.432.517.01

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.88-0.77-0.12--
Lease Payments
-0.9-0.88-0.77-0.12--
Net Debt Issued (Repaid)
-0.9-0.88-0.77-0.12--
Common Dividends Paid
-74.3-44.66-31.76---
Financing Cash Flow
-75.21-45.53-32.54-0.12--

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-13.11-74.1712.924.94102.47-2.18

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-7.5466.98128.76107.9697.01-10.96
Free Cash Flow Growth
--47.98%19.26%11.29%--
Free Cash Flow Margin
-4.43%21.67%51.70%59.50%150.15%-44.61%
Free Cash Flow Per Share
-0.110.971.871.571.41-0.16
Levered Free Cash Flow
-26.3722.6282.3567.8893.19-5.52
Unlevered Free Cash Flow
-26.3622.6482.3767.8893.19-5.52
Free Cash Flow After Leases
-8.4466.1127.98107.8597.01-10.96

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.030.030.040--
Cash Income Tax Paid
6.776.770.150.02--
Change in Working Capital
-37.62-91.98-0.2813.7682.47-0.32